Analyst Price Targets — GRAL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 10, 2026 9:51 am | Bradley Bowers | Mizuho Securities | $58.00 | $45.76 | TheFly | Grail initiated with a Neutral at Mizuho |
| April 10, 2026 8:43 am | — | Piper Sandler | $54.00 | $45.76 | TheFly | Grail initiated with a Neutral at Piper Sandler |
| February 24, 2026 12:35 pm | Kallum Titchmarsh | Morgan Stanley | $60.00 | $43.03 | TheFly | Grail price target lowered to $60 from $110 at Morgan Stanley |
| February 20, 2026 11:59 am | Catherine Ramsey Schulte | Robert W. Baird | $82.00 | $101.53 | TheFly | Grail price target lowered to $82 from $113 at Baird |
| February 20, 2026 11:49 am | — | Canaccord Genuity | $80.00 | $101.53 | TheFly | Grail price target lowered to $80 from $105 at Canaccord |
| February 17, 2026 10:11 am | — | Robert W. Baird | $113.00 | $97.50 | TheFly | Grail initiated with an Outperform at Baird |
| January 26, 2026 2:35 pm | — | Guggenheim | $130.00 | $107.58 | TheFly | Grail price target raised to $130 from $100 at Guggenheim |
| December 1, 2025 9:28 pm | — | Morgan Stanley | $110.00 | $98.27 | TheFly | Grail assumed with an Equal Weight at Morgan Stanley |
| November 12, 2025 11:13 am | Subbu Nambi | Guggenheim | $100.00 | $83.39 | StreetInsider | Guggenheim Upgrades GRAIL, Inc. (GRAL) to Buy |
| October 22, 2025 10:34 am | Kyle Mikson | Canaccord Genuity | $85.00 | $78.28 | TheFly | Grail price target raised to $85 from $75 at Canaccord |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for GRAL

Grail told investors cash burn would be no more than $290 million while guiding to milestones the Company may have known were at risk NEW YORK, April 15, 2026 /PRNewswire/ -- Grail, Inc. (NASDAQ: GRAL) investors lost approximately half the value of their holdings when the stock plunged roughly 50% following disclosure that the NHS Galleri trial missed its primary endpoint. If you lost money on GRAL, submit your…

Carnegie Investment Counsel lowered its stake in GRAIL, Inc. (NASDAQ: GRAL) by 13.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 213,050 shares of the company's stock after selling 32,265 shares during the period. Carnegie Investment Counsel

GRAIL, Inc. (NASDAQ: GRAL - Get Free Report) CFO Aaron Freidin sold 45,806 shares of the firm's stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $49.92, for a total transaction of $2,286,635.52. Following the transaction, the chief financial officer owned 260,669 shares in the company, valued at

GRAIL, Inc. (NASDAQ: GRAL - Get Free Report) President Joshua Ofman sold 61,665 shares of the firm's stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $49.92, for a total transaction of $3,078,316.80. Following the completion of the transaction, the president directly owned 371,216 shares of the company's

GRAIL, Inc. (NASDAQ: GRAL - Get Free Report) CEO Robert Ragusa sold 123,502 shares of the company's stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $49.92, for a total transaction of $6,165,219.84. Following the sale, the chief executive officer directly owned 518,582 shares in the
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GRAL.
U.S. House Trading
No House trades found for GRAL.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
